Ampio Pharmaceuticals, Inc.

DB:APH Stock Report

Market Cap: €1.5m

Ampio Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Mike Martino

Chief executive officer

US$668.1k

Total compensation

CEO salary percentage82.0%
CEO tenure2.1yrs
CEO ownership0.5%
Management average tenureno data
Board average tenure2.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mike Martino's remuneration changed compared to Ampio Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$9m

Jun 30 2023n/an/a

-US$14m

Mar 31 2023n/an/a

-US$15m

Dec 31 2022US$668kUS$548k

-US$16m

Sep 30 2022n/an/a

-US$20m

Jun 30 2022n/an/a

-US$18m

Mar 31 2022n/an/a

-US$19m

Dec 31 2021US$1mUS$60k

-US$17m

Compensation vs Market: Mike's total compensation ($USD668.14K) is above average for companies of similar size in the German market ($USD418.12K).

Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.


CEO

Mike Martino (66 yo)

2.1yrs

Tenure

US$668,141

Compensation

Mr. Michael A. Martino, also known as Mike, has served as Chairman of the Board of Directors at Ampio Pharmaceuticals, Inc. since November 2021 until November 22, 2022 and served as its Interim Chairman of...


Board Members

NamePositionTenureCompensationOwnership
Michael Martino
CEO & Director2.2yrsUS$668.14k0.46%
€ 6.8k
David Bar-Or
Founder & Chairman of Scientific Advisory Board3yrsUS$145.60kno data
J. Buchi
Independent Chairman2.2yrsUS$99.71k0.88%
€ 13.0k
David Stevens
Independent Director12.5yrsUS$65.54k0.62%
€ 9.2k
Elizabeth Jobes
Independent Director1.8yrsUS$108.91k0%
€ 0

2.2yrs

Average Tenure

68yo

Average Age

Experienced Board: APH's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.